MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57
Published . Updated .
The average one-year price target for MIRA Pharmaceuticals (NASDAQCM:MIRA) (DB:K6S) has been revised to $3.57 / share. This is an increase of 16.67% from the prior estimate of $3.06 dated January 11, 2026. These figures represent aggregate analyst targets collected by Fintel, rat
Directly affected
- MIRA Mira Pharmaceuticals
Named in this report.
Indirectly affected
- DOGG FT VEST DJIA DOGS 10 TARGET INCOME ETF
GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- FGSI FT VEST GROWTH STRENGTH & TARGET INCOME ETF
GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDB ISHARES LIFEPATH TARGET DATE 2030 ETF
GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDC ISHARES LIFEPATH TARGET DATE 2035 ETF USD
GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDE ISHARES LIFEPATH TARGET DATE 2045 ETF USD
GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The average one-year price target for MIRA Pharmaceuticals (NASDAQCM:MIRA) (DB:K6S) has been revised to $3.57 / share. This is an increase of 16.67% from the prior estimate of $3.06 dated January 11, 2026. These figures represent aggregate…
Source: Nasdaq Markets
The price since 3 Oct 2026: Mira Pharmaceuticals (MIRA) versus the S&P 500
Since the first closing price after “MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57,” Mira Pharmaceuticals (MIRA) is -12.21%. The S&P 500 fund (SPY) is -1.08% over the same days, a -11.13% difference versus the market.
Who gains and who loses around Mira Pharmaceuticals (MIRA)
Companies mentioned with this story
- MIRA Mira Pharmaceuticals
For “MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57,” Mira Pharmaceuticals (MIRA) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names MIRA PHARMACEUTICALS INC in the headline; GA resolved that company to MIRA
- DOGG Ft Vest Djia Dogs 10 Target Income Etf
Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is linked, with no stored direction, medium confidence in the 3 Oct 2026 story “MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57.” Reason on file: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- FGSI Ft Vest Growth Strength & Target Income Etf
For “MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57,” Ft Vest Growth Strength & Target Income Etf (FGSI) is linked, with no stored direction, medium confidence. Reason on file: GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDB Ishares Lifepath Target Date 2030 Etf
Ishares Lifepath Target Date 2030 Etf (ITDB) is linked, with no stored direction, medium confidence in the 3 Oct 2026 story “MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57.” Reason on file: GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDC Ishares Lifepath Target Date 2035 Etf Usd
For “MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57,” Ishares Lifepath Target Date 2035 Etf Usd (ITDC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDE Ishares Lifepath Target Date 2045 Etf Usd
For “MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57,” Ishares Lifepath Target Date 2045 Etf Usd (ITDE) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
In “MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57,” T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is linked, with no stored direction, medium confidence. Reason on file: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Mira Pharmaceuticals (MIRA)
The 3 Oct 2026 story “MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57” names Mira Pharmaceuticals (MIRA) because of this story.
Mira Pharmaceuticals (MIRA) is on the page because The reported development directly names MIRA PHARMACEUTICALS INC in the headline; GA resolved that company to MIRA
Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is here too. Its reason reads: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Mira Pharmaceuticals (MIRA), and the dates in the story
DOGG traded between 20.68 and 22.21 across 20 sessions. The latest close on file is 21.99. FGSI traded between 20.20 and 20.62 across 5 sessions. The latest close on file is 20.27. MIRA traded between 0.63 and 0.75 across 11 sessions. The latest close on file is 0.64.
What the saved facts support for Mira Pharmaceuticals (MIRA)
46 out of 100
“MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.